替妥木单抗治疗后斜视手术的结局
这项多中心回顾性病例系列报告了28例甲状腺眼病(TED)患者在接受替妥木单抗治疗后,因斜视性复视而接受眼外肌手术的结果。16例(57%)患者一次手术后复视消失,3例(11%)选择棱镜眼镜矫正残余复视,2例(7%)使用代偿头位,1例(4%)有间歇性复视但功能改善,这些被视为治疗成功。3例(11%)需要再次手术,且第二次手术后复视均消失。作者结论认为,多数需要手术的患者获得良好结局,成功率与替妥木单抗可用之前的系列相当。
要点
- 16例(57%)患者一次斜视手术后复视消失。
- 3例(11%)需再次手术,二次手术后复视均消失。
- 作者认为成功率与替妥木单抗可用前的系列相当。
核心结论
- 多数因替妥木单抗治疗后斜视性复视而需要手术的患者获得良好结局,成功率与替妥木单抗可用之前发表的系列相当。
研究设计与样本
- 多中心、回顾性、病例系列,纳入7个学术中心的28例因替妥木单抗治疗后斜视性复视而接受眼外肌手术的患者。
主要发现
- 16例(57%)患者一次手术后复视消失。
- 3例(11%)选择棱镜眼镜矫正残余复视,2例(7%)使用代偿头位解决复视,1例(4%)有间歇性复视且功能改善(选择不用棱镜或进一步手术),这些被视为治疗成功。
- 3例(11%)需要再次手术,且第二次手术后复视均消失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the results of patients undergoing surgical treatment for strabismic diplopia in thyroid eye disease (TED) following teprotumumab. DESIGN: Multicenter, retrospective, case series. METHODS: We report 28 patients who underwent extraocular muscle surgery for strabismic diplopia after treatment with teprotumumab at 7 different academic centers. Elapsed time from last teprotumumab dose to the date of surgery, previous orbital decompression, primary preoperative horizontal and vertical deviation, surgical procedure, and 2-month postoperative results were collected from the patient records. RESULTS: Sixteen (57%) patients were diplopia-free after 1 surgery. Three (11%) chose prism spectacles to correct residual diplopia, 2 (7%) used compensatory head posture to resolve diplopia, and 1 (4%) had intermittent diplopia and was functionally improved (choosing no prisms or further surgery). These were considered treatment successes. Three (11%) patients required reoperation, and all were diplopia-free after their second procedure. CONCLUSIONS: Most patients requiring surgery for strabismic diplopia following teprotumumab achieve good outcomes with success rates comparable to series published before the availability of teprotumumab.
引用
- Hilliard G, Pruett J, Donahue SP, et al. Outcomes of Strabismus Surgery Following Teprotumumab Therapy. Am J Ophthalmol. 2024. PMID: 38191066. doi:10.1016/j.ajo.2024.01.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。